| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28ecb9d2655209cb54a6fcae204d4cba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate |
1998-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb63b3151f45801b242785e7c07b63f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4112513d97be83c39c84e0e167d39d2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4eabbc692200465a835cd878f91ecc |
| publicationDate |
2000-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SK-183499-A3 |
| titleOfInvention |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
| abstract |
A new method and compositions for the treatment of glaucoma and ocular hypertension are described. The method is based on the usage of EP1 prostanoid receptor agonists which effectively reduce the intraocular pressure but have no, or reduced effect on iris pigmentation. The prostaglandin analogue which is an EP1 selective agonist is applied topically on the eye. |
| priorityDate |
1997-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |